Track the 삼성생명 share price and the full insider trade history of the company, a listed issuer based in South Korea. Shares are listed on KR KR, under the oversight of DART (FSS). Operating in the Banks sector, 삼성생명 has recorded 25 insider filings. Market capitalisation: €69,226.1bn. The latest transaction was disclosed on 22 May 2026 (Other). Among the most active insiders: 삼성물산. The full history is accessible without an account.
25
Insider Decl.
0
Thresholds
·
3 ops.
Buy Volume
·
6 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate 삼성생명 Buy (bullish), based on 18 analysts. Average price target: ₩358,472.
22Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 10,969 of 26,213 companies
56.1
score / 100
Value
63
Quality
49
FCF yld8.3%
Earn yld3.8%
EV/EBITDA10.4x
ROE5.3%
Gross mgn·
Net mgn8.1%
Debt/EBITDA2.8x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.